Cargando…

Identification of Selective BRD9 Inhibitor via Integrated Computational Approach

Bromodomain-containing protein 9 (BRD9), a member of the bromodomain and extra terminal domain (BET) protein family, works as an epigenetic reader. BRD9 has been considered an essential drug target for cancer, inflammatory diseases, and metabolic disorders. Due to its high similarity among other iso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Maria Mushtaq, Ashraf, Sajda, Nure-e-Alam, Mohammad, Qureshi, Urooj, Khan, Khalid Mohammed, Ul-Haq, Zaheer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655433/ https://www.ncbi.nlm.nih.gov/pubmed/36362300 http://dx.doi.org/10.3390/ijms232113513

Ejemplares similares

Exploring Novel N-Myristoyltransferase Inhibitors: A Molecular Dynamics Simulation Approach
por: Khalil, Ruqaiya, et al.
Publicado: (2019)

Quantum mechanics and 3D-QSAR studies on thienopyridine analogues: inhibitors of IKKβ
por: Ul-Haq, Zaheer, et al.
Publicado: (2020)

3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model
por: Ul-Haq, Zaheer, et al.
Publicado: (2016)

Probing CAS database as prospective antiviral agents against SARS-CoV-2 main protease
por: Zia, Komal, et al.
Publicado: (2021)

Exploration of the structural requirements of Aurora Kinase B inhibitors by a combined QSAR, modelling and molecular simulation approach
por: Ashraf, Sajda, et al.
Publicado: (2021)

Identification of potential TNF-α inhibitors: from in silico to in vitro studies
por: Zia, Komal, et al.
Publicado: (2020)

Synthesis and dynamics studies of barbituric acid derivatives as urease inhibitors
por: Barakat, Assem, et al.
Publicado: (2015)

The 4-(dimethylaminoalkyl)piperazine inhibitors of α-glucosidase: allosteric enzyme inhibition and identification of interacting chemical groups
por: GHANI, Usman, et al.
Publicado: (2022)

Phenylpyrazalopyrimidines as Tyrosine Kinase Inhibitors: Synthesis, Antiproliferative Activity, and Molecular Simulations
por: Chhikara, Bhupender S., et al.
Publicado: (2020)

Theoretical exploration of the binding selectivity of inhibitors to BRD7 and BRD9 with multiple short molecular dynamics simulations
por: Wang, Lifei, et al.
Publicado: (2022)

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
por: Martin, Laetitia J., et al.
Publicado: (2016)

Synthesis of a New Class of Spirooxindole–Benzo[b]Thiophene-Based Molecules as Acetylcholinesterase Inhibitors
por: Barakat, Assem, et al.
Publicado: (2020)

Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9
por: Kottom, Theodore J., et al.
Publicado: (2022)

Virtual Screening, Synthesis and Biological Evaluation of Streptococcus mutans Mediated Biofilm Inhibitors
por: Atta, Lubna, et al.
Publicado: (2022)

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor**
por: Clark, Peter G K, et al.
Publicado: (2015)

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor
por: Clark, Peter G. K., et al.
Publicado: (2015)

Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid
por: Yaqoob, Sana, et al.
Publicado: (2021)

Insights into the Ligand Binding to Bromodomain-Containing Protein 9 (BRD9): A Guide to the Selection of Potential Binders by Computational Methods
por: De Vita, Simona, et al.
Publicado: (2021)

Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells
por: Zhou, Lixin, et al.
Publicado: (2021)

Design of New and Potent Diethyl Thiobarbiturates as Urease Inhibitors: A Computational Approach
por: Wadood, Abdul, et al.
Publicado: (2014)

Docking based 3D-QSAR studies applied at the BRAF inhibitors to understand the binding mechanism
por: Mahmood, Uzma, et al.
Publicado: (2012)

Synthesis of 2-Aminopyrimidine Derivatives and Their Evaluation as β-Glucuronidase Inhibitors: In Vitro and In Silico Studies
por: Iqbal, Sarosh, et al.
Publicado: (2022)

Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
por: Hügle, Martin, et al.
Publicado: (2016)

An in-silico evaluation of COVID-19 main protease with clinically approved drugs
por: Tachoua, Wafa, et al.
Publicado: (2020)

BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell
por: Deeney, Jude T., et al.
Publicado: (2016)

Natural coumarins from Murraya paniculata as mixed-type inhibitors of cholinesterases: In vitro and in silico investigations
por: Khalid, Asaad, et al.
Publicado: (2023)

3D-QSPR Method of Computational Technique Applied on Red Reactive Dyes by Using CoMFA Strategy
por: Mahmood, Uzma, et al.
Publicado: (2011)

Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors
por: Uddin, Reaz, et al.
Publicado: (2022)

Identification of a Novel Class of BRD4 Inhibitors by Computational Screening and Binding Simulations
por: Allen, Bryce K., et al.
Publicado: (2017)

BRD4 inhibitors block telomere elongation
por: Wang, Steven, et al.
Publicado: (2017)

Cheminformatics-Based Discovery of Potential Chemical Probe Inhibitors of Omicron Spike Protein
por: Khan, Salman Ali, et al.
Publicado: (2022)

Discovery of Potential Chemical Probe as Inhibitors of CXCL12 Using Ligand-Based Virtual Screening and Molecular Dynamic Simulation
por: Haider, Sajjad, et al.
Publicado: (2020)

BRD9 regulates interferon-stimulated genes during macrophage activation via cooperation with BET protein BRD4
por: Ahmed, Nasiha S., et al.
Publicado: (2021)

The mTORC1–G9a–H3K9me2 axis negatively regulates autophagy in fatty acid–induced hepatocellular lipotoxicity
por: Mushtaq, Arjamand, et al.
Publicado: (2023)

Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9)
por: Basuroy, Tupa, et al.
Publicado: (2022)

Targeting BRD9 for Cancer Treatment: A New Strategy
por: Zhu, Xiuzuo, et al.
Publicado: (2020)

BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma
por: Weisberg, Ellen, et al.
Publicado: (2022)

BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
por: Kurata, Keiji, et al.
Publicado: (2023)

Analyzing the Behavior of Neuronal Pathways in Alzheimer's Disease Using Petri Net Modeling Approach
por: Ashraf, Javaria, et al.
Publicado: (2018)

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
por: Coudé, Marie-Magdelaine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nag0jjoj77l16i4acijup1lcnu